Page 11 - Dabur India

FMCG firms bring jobs to small towns as markets show signs of revival

In contrast, auto companies and their dealers have not been that bullish with hiring, despite tractor sales increasing in May

Demand set to reach pre-Covid levels by Q3 or Q4 in some sectors

In others, it's too early to predict; while in some, once pent-up demand has been satisfied, it could fall again

India Inc takes cautious approach to Covid disclosures mandated by Sebi

Most firms not indicating financial impact

Capacity utilisation stands at 90% of pre-Covid levels: Hindustan Unilever

All its factories and warehouses are open, barring the one in Assam.

Dabur India recovers 4% from day's low, trades 2% up despite weak Q4 nos

As the lockdown restrictions eased gradually, Dabur has been at the forefront of delivering authentic Ayurvedic solutions to meet the emerging Health Care needs of consumers in the post-COVID market.

Market Ahead, May 27: All you need to know before the opening bell

Today, a total of 21 companies, including Dabur India, Sun Pharma, and United Spirits are scheduled to announce their results.

Lockdown 3.0: Rural India may drive demand recovery amid Covid-19 crisis

Top executives at auto, tractor and consumer packaged goods firms are optimistic. They are betting on the reverse migration of labourers boosting consumption and prediction of a favourable monsoon.

Dabur looks to sharpen its herbal edge as ayurvedic products get a push

As ayurvedic formulations get a renewed push in the fight against Covid-19, can one of the oldest players in the segment step up its game?

Covid-19 impact: Restrictions on movement still a pain point for FMCG firms

According to the Federation of West Bengal Truck Operators' Association (FWBTOA), truck availability has only improved marginally around 10 per cent of a total 9 million trucks in India.

Dabur, Himalaya witness spike in sales of Ayurvedic products amid Covid-19

For Himalaya, the surge in demand has been seen particularly in its Pure Herbs range such as Guduchi, Tulasi, Amalaki, Ashwagandha and others

Lockdown 2.0: India Inc lends help to dealers amid coronavirus crisis

Incentive hikes, credit period extension among steps taken to support them during corona crisis

Hindustan Unilever's valuation premium over peers hits record high

Trading at 77x, its trailing 12-month net profit against industry average of about 43x

Amul brings nostalgia back in ads to stay relevant amid Covid-19 lockdown

Leaning in on nostalgia and its long-standing relationship with customers, the legacy brand strives to be seen and heard amidst a lockdown

FMCG leaders mark down overall growth to 3% amid coronavirus outbreak

According to Nielsen, panic buying of food items and hygiene products has pushed up growth rates of food and non-food categories by 300 and 400 basis points respectively.

Weekly stock picks by Religare Broking: Buy Ajanta Pharma, Dabur India

Ajanta Pharma's stock has seen a fresh breakout from the trading range of roughly 1350-1480 levels

FMCG firms see slow demand revival as growth triggers remain weak

According to experts, discretio­nary businesses like food services and jewellery continue to have a greater presence in urban areas versus rural areas, where consumption slowdown has been pronounced.

FMCGs welcome Budget, says reduction in I-T slabs to drive consumption

Terming it as "incremental budget", Dabur India CEO Mohit Malhotra said the government continues to focus on farmers' income and is offering significant sops at the lower end of the spectrum

Dabur India surges 5% after Q3 result beats Street estimates

The management, however, said the near-term outlook for demand growth remains challenging with most key categories reporting a steady decline in value and volume growth.

Dabur's strategic moves pays well in Dec quarter, analysts remain positive

Topline up 7% led by 5.6% rise in volumes on faster rural sales, while pre-tax profit up over 9%

Dabur's growth potential justifies premium valuation of its stock

Focus on power brands and rural expansion augur well for the stock, trading at 43 times its FY21 estimated earnings